Approval · Notice of Compliance 5903 · 2004
FRISIUM: Notice of Compliance 5903
Issued November 17, 2004
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 5903
- Date
- November 17, 2004
- Company
- Pharmascience Inc.Montreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Anticonvulsant for adjuctive therapy
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| FRISIUM | 02221799 | Cancelled Post Market |
Medicinal ingredients
- CLOBAZAM 10 MG per TAB